
Peptide therapy has gained attention in the wellness and performance space, but it is often promoted faster than the science can support. Many patients encounter bold claims online without clear explanations, medical oversight, or an honest discussion of what is proven versus what is still being studied.
At High Mark Internal Medicine, peptide therapy is approached with curiosity, caution, and clinical responsibility. Board-certified internal medicine physician Dr. Erik Contreras believes new therapies deserve careful evaluation, not trends or shortcuts. He stays current through ongoing medical education, endocrinology refreshers, physician-led lectures, and national conferences focused on emerging research and safety data.
Peptide therapy is never a one-size-fits-all solution. It is considered only after a comprehensive medical evaluation, a review of the available evidence, and a clear discussion of potential benefits, limitations, and unknowns. When used, peptides are integrated into a broader, medically guided plan that prioritizes metabolic health, hormone balance, lifestyle optimization, and long-term disease prevention.
Our goal is not to chase what is popular, but to responsibly explore what may be beneficial while protecting patients from misinformation, unnecessary risk, and unrealistic promises. Peptide therapy at High Mark remains exactly what it should be: a carefully considered medical tool, not a retail product.
Peptide therapy may benefit adults who are experiencing:
We'd love to hear from you. How can we help?
